Anastassova, N.; Aluani, D.; Hristova-Avakumova, N.; Tzankova, V.; Kondeva-Burdina, M.; Rangelov, M.; Todorova, N.; Yancheva, D.
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease. Antioxidants 2022, 11, 884.
https://doi.org/10.3390/antiox11050884
AMA Style
Anastassova N, Aluani D, Hristova-Avakumova N, Tzankova V, Kondeva-Burdina M, Rangelov M, Todorova N, Yancheva D.
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease. Antioxidants. 2022; 11(5):884.
https://doi.org/10.3390/antiox11050884
Chicago/Turabian Style
Anastassova, Neda, Denitsa Aluani, Nadya Hristova-Avakumova, Virginia Tzankova, Magdalena Kondeva-Burdina, Miroslav Rangelov, Nadezhda Todorova, and Denitsa Yancheva.
2022. "Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease" Antioxidants 11, no. 5: 884.
https://doi.org/10.3390/antiox11050884
APA Style
Anastassova, N., Aluani, D., Hristova-Avakumova, N., Tzankova, V., Kondeva-Burdina, M., Rangelov, M., Todorova, N., & Yancheva, D.
(2022). Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease. Antioxidants, 11(5), 884.
https://doi.org/10.3390/antiox11050884